Glycan Profiling and Differential Analysis to Elucidate Functional Differences in Therapeutic Antibodies
Europe Broadcast: Thursday July 31st, 2014 at 2:00 PM BST / 3:00 PM CEST / 9:00 AM EDT
Asia-Pacific Broadcast: Friday, August 1st , 2014 at 11:00 AM CST / 12:00 PM JST / 11:00 PM EDT
In this free webcast, experts from Agilent and Gilead Science will discuss the challenges of characterization of glycan profiles throughout various phases of therapeutic mAbs development.
Audience members will learn about rapid glycopeptide and glycan analysis of monoclonal antibodies using LC, LC/MS and HILIC, and a microfluidic-based HPLC-Chip coupled to an Agilent Accurate-Mass Q-TOF LC/MS. The discussion will include differential analysis using MassHunter Molecular Feature Extractor and other software tools to elucidate functional differences in the studied antibodies.
Register free at www.biopharminternational.com/analysis
Sponsored by Agilent Technologies
Fast, Robust LC and LCMS Workflows for the Comprehensive Characterization of Bio-Therapeutic Proteins
Available until June 3, 2015
Would you like to reduce method development time for mAb characterization from weeks to minutes? Have finalized methods that are more robust than previous methods? The webinar will describe new technology and workflows for mAb characterization with advice on simplified method develop`ment..
Register free at www.biopharminternational.com/fast
Sponsored by Thermo Fisher Scientific
Delivering Biologics with a Difference
Available until June 5, 2015
As the biologics market continues to grow with additional launches, expanding indications, and approvals of biosimilars, the delivery platform will play a more critical role in product differentiation. Join us for this webinar to explore the advantages, challenges, case studies and science behind delivering biologics with a difference.
Register free at www.pharmtech.com/difference
Sponsored by Baxter BioPharma Solutions
MAb manufacturing: where are we headed, cost or capabilities?
Available until May 27, 2015
MAb manufacturing, where are we heading? Join the discussion with Gunter Jagschies of GE Healthcare Life Sciences.
Register free at www.biopharminternational.com/MAb
Sponsored by GE Healthcare
Effective Viral Contamination Testing Programs for Biologics Product Manufacturing
Available until May 20, 2015
Biopharmaceutical manufacturers need comprehensive virus testing programs to ensure product safety throughout various manufacturing stages. Learn how to establish or improve practices for effective virus testing programs and review test methods for virus detection and quantitation throughout the biopharmaceutical manufacturing process.
Register free at www.biopharminternational.com/virustesting
Sponsored by SGS Life Science Services
Best Practices for Effective Environmental Monitoring Program in Bio/Pharmaceutical Production
Available until April 22, 2015
Contamination poses a threat to process and product integrity, as well as patient safety. A comprehensive environmental monitoring program can ensure that manufacturing areas, cleanrooms, production equipment, and water and gas utilities are free of viable and non-viable contamination and meet regulatory requirements. In this webcast, learn about pertinent regulatory and quality standards, as well as best practices for establishing and maintaining an effective environmental monitoring program. Review measures for testing pharmaceutical water systems according to U.S. Pharmacopeial Convention (USP) water monograph as well as procedures to evaluate the purity of production gases.
Register free at www.pharmtech.com/emp
Sponsored by SGS Life Science Services
Increase Control over Quality Management Through Strong Supplier Relationships
Available until April 2, 2015
Understand the regulatory obligations of bio/pharmaceutical companies in a global, outsourced supply chain and challenges with building effective supplier relationships. Learn how a supplier quality management system should provide the ability to aggregate quality metrics in a consistent, measurable, normalized, and repeatable way.
Register free at www.pharmtech.com/relationships
Sponsored by Sparta Systems
Navigating the Analytical Development Challenges for Bioprocess Residuals and Impurities
Available until April 1, 2015
Tracking the clearance of host cell components and process additives residuals is an essential part of process development and characterization of biopharmaceuticals.
In this webinar, learn about challenges presented by residuals, regulatory expectations, analytical approaches for cell- and process-associated residuals, a platform method technology for residuals, and matrix effects.
Register free at www.pharmtech.com/navigating
Sponsored by Eurofins Lancaster Laboratories
Identifying, Analyzing, and Controlling Particles throughout the Biopharmaceutical Product Lifecycle
Available until March 25, 2015
Preformulation screening can identify potential problems and form the basis for long-term stability of biopharmaceutical drug products. One of the main challenges in the development of stable biopharmaceutical products is the control of aggregation and particulate formation. Review how particles can potentially develop through the life cycle of a drug, understand regulatory expectations, and assess analytical techniques available to assess protein aggregation and particulates for innovator drugs and biosimilars.
Register free at www.biopharminternational.com/particles
Sponsored by SGS Life Science Services
Streamlining Recombinant Protein Manufacturing
Available until December 12, 2014
Review the common challenges with recombinant protein production from E. coli, which include protein aggregation, lengthy purification and inefficient refolding processes. A system that requires fewer purification steps and no refolding, with the goals of reducing the number of potential difficulties, lowering costs, and speeding time to market will be discussed.
Register free at: www.biopharminternational.com/streamlining
Sponsor: Ajinomoto Althea
Advancing High Resolution Biopharmaceutical Analytics: Why intact mass, peptide mapping, and glycan analysis should be routine and automated across your organization
Available until December 3, 2014
This webinar will focus on advantages of using the Waters Biopharmaceutical Platform Solution with UNIFI Software to assess, monitor, and compare the critical quality attributes of innovator and biosimilar biopharmaceuticals. The speakers will look beyond the high-resolution UPLC/QTof MS data gained during an analysis, to how informatics can facilitate a better understanding of the similarities and differences between an innovator and a biosimilar product.
Register Free at www.biopharminternational.com/highres
Meeting Regulatory and Technical Requirements for Organic Impurity Analysis
Available until October 1, 2014
Gain technical and regulatory insight for organic impurity control and analysis for pharmaceuticals. Learn from leading industry experts on selecting the appropriate analytical methods for detection, analysis, and quantification of organic impurities.
Register Free at http://www.pharmtech.com/organic
Sponsor: SGS Life Science Services
Regulatory, Biosafety, and Clinical Considerations for Vaccine Development
Available until June 11, 2014
The development and approval processes for a vaccine requires understanding of regulatory, biosafety, and clinical issues. This webcast provides a global perspective of these key issues, plus a detailed a case study examining viral challenge testing for vaccine development in a phase I clinical pharmacology unit.
Register Free at www.biopharminternational.com/vaccine
Sponsor: SGS Life Science Solutions
Integrated Solutions for Maintaining Product Quality without Sacrificing Titer
Available until July 17, 2014
To maintain product quality, or sacrifice titers? That is the question. Is a trade-off always necessary? This webcast will consider this age-old question and what solutions exist to help you avoid having to choose between the two.
Register Free at www.biopharminternational.com/titer
Sponsor: Life Technologies
For more multimedia content from Biopharm International, including podcasts and videos, click here.